CCL2 anticorps (Middle Region)
Aperçu rapide pour CCL2 anticorps (Middle Region) (ABIN926929)
Antigène
Voir toutes CCL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée
- Chien
-
Purification
- Purified
-
Immunogène
- CCL2 antibody was raised in rabbit using the middle region of CCL2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CCL2 Blocking Peptide, (ABIN936932), is also available for use as a blocking control in assays to test for specificity of this CCL2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Autre désignation
- CCL2
-
Sujet
- CCL2 is a chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. CCL2 augments monocyte anti-tumor activity. CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. CCL2 may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. Synonyms: Polyclonal CCL2 antibody, Anti-CCL2 antibody, chemokine, C-C motif ligand 2 antibody, GDCF-2 antibody, GDCF-2 HC11 antibody, HC11 antibody, HSMCR30 antibody, MCAF antibody, MCP-1 antibody, MCP1 antibody, MGC9434 antibody, SCYA2 antibody, SMC-CF antibody.
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, Phosphorylation & l'infection par le SRAS-CoV-2
Antigène
-